Literature DB >> 21056654

The catalytic class I(A) PI3K isoforms play divergent roles in breast cancer cell migration.

Angela De Laurentiis1, Olivier E Pardo, Andrea Palamidessi, Shaun P Jackson, Simone M Schoenwaelder, Ernst Reichmann, Giorgio Scita, Alexandre Arcaro.   

Abstract

Transforming growth factor-β (TGFβ) plays an important role in breast cancer metastasis. Here phosphoinositide 3-kinase (PI3K) signalling was found to play an essential role in the enhanced migration capability of fibroblastoid cells (FibRas) derived from normal mammary epithelial cells (EpH4) by transduction of oncogenic Ras (EpRas) and TGFβ1. While expression of the PI3K isoform p110δ was down-regulated in FibRas cells, there was an increase in the expression of p110α and p110β in the fibroblastoid cells. The PI3K isoform p110β was found to specifically contribute to cell migration in FibRas cells, while p110α contributed to the response in EpH4, EpRas and FibRas cells. Akt, a downstream targets of PI3K signalling, had an inhibitory role in the migration of transformed breast cancer cells, while Rac, Cdc42 and the ribosomal protein S6 kinase (S6K) were necessary for the response. Together our data reveal a novel specific function of the PI3K isoform p110β in the migration of cells transformed by oncogenic H-Ras and TGF-β1.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21056654     DOI: 10.1016/j.cellsig.2010.10.021

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  3 in total

1.  Differential roles of CXCL2 and CXCL3 and their receptors in regulating normal and asthmatic airway smooth muscle cell migration.

Authors:  Laila A Al-Alwan; Ying Chang; Andrea Mogas; Andrew J Halayko; Carolyn J Baglole; James G Martin; Simon Rousseau; David H Eidelman; Qutayba Hamid
Journal:  J Immunol       Date:  2013-07-31       Impact factor: 5.422

Review 2.  A Review of Phosphocreatine 3 Kinase δ Subtype (PI3Kδ) and Its Inhibitors in Malignancy.

Authors:  Qiong Xiang; Shuai Dong; Xian-Hui Li
Journal:  Med Sci Monit       Date:  2021-10-09

3.  Nicotine reduces effectiveness of doxorubicin chemotherapy and promotes CD44+CD24- cancer stem cells in MCF-7 cell populations.

Authors:  Leyla Türker Şener; Celal Güven; Aziz Şener; Suzan Adin Çinar; Seyhun Solakoğlu; Işil Albeniz
Journal:  Exp Ther Med       Date:  2018-05-10       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.